| More than smell—COVID-19 is associated with severe impairment of smell, taste, and chemesthesis V Parma, K Ohla, MG Veldhuizen, MY Niv, CE Kelly, AJ Bakke, ... Chemical senses 45 (7), 609-622, 2020 | 497 | 2020 |
| Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research JW Messinger, F Trémeau, D Antonius, E Mendelsohn, V Prudent, ... Clinical psychology review 31 (1), 161-168, 2011 | 337 | 2011 |
| Childhood trauma and prodromal symptoms among individuals at clinical high risk for psychosis JL Thompson, M Kelly, D Kimhy, JM Harkavy-Friedman, S Khan, ... Schizophrenia research 108 (1-3), 176-181, 2009 | 155 | 2009 |
| Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms RC Gerkin, K Ohla, MG Veldhuizen, PV Joseph, CE Kelly, AJ Bakke, ... Chemical Senses, 2020 | 145 | 2020 |
| Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis CM Corcoran, D Kimhy, A Stanford, S Khan, J Walsh, J Thompson, ... Schizophrenia research 106 (2-3), 286-293, 2008 | 110 | 2008 |
| Low Vitamin D levels predict clinical features of schizophrenia K Cieslak, J Feingold, D Antonius, J Walsh-Messinger, R Dracxler, ... Schizophrenia research 159 (2), 543-545, 2014 | 98 | 2014 |
| Theory of Mind in patients at clinical high risk for psychosis AD Stanford, J Messinger, D Malaspina, CM Corcoran Schizophrenia research 131 (1-3), 11-17, 2011 | 97 | 2011 |
| Negative symptoms, past and present: a historical perspective and moving to DSM-5 D Malaspina, J Walsh-Messinger, W Gaebel, LM Smith, A Gorun, ... European Neuropsychopharmacology 24 (5), 710-724, 2014 | 85 | 2014 |
| Telomere length, family history, and paternal age in schizophrenia D Malaspina, R Dracxler, J Walsh‐Messinger, S Harlap, RR Goetz, ... Molecular genetics & genomic medicine 2 (4), 326-331, 2014 | 60 | 2014 |
| The kids are not alright: a preliminary report of post-COVID syndrome in university students J Walsh-Messinger, H Manis, A Vrabec, J Sizemore, K Bishof, M Debidda, ... Journal of American College Health 71 (5), 1367-1373, 2023 | 56 | 2023 |
| Olfactory acuity is associated with mood and function in a pilot study of stable bipolar disorder patients C Hardy, M Rosedale, JW Messinger, K Kleinhaus, N Aujero, H Silva, ... Bipolar disorders 14 (1), 109-117, 2012 | 53 | 2012 |
| De novo mutations from sporadic schizophrenia cases highlight important signaling genes in an independent sample TM Kranz, S Harroch, O Manor, P Lichtenberg, Y Friedlander, M Seandel, ... Schizophrenia research 166 (1), 119-124, 2015 | 49 | 2015 |
| Olfactory processing, sex effects and heterogeneity in schizophrenia D Malaspina, R Goetz, A Keller, JW Messinger, G Bruder, D Goetz, ... Schizophrenia research 135 (1), 144-151, 2012 | 45 | 2012 |
| Later paternal age and sex differences in schizophrenia symptoms PJ Rosenfield, K Kleinhaus, M Opler, M Perrin, N Learned, R Goetz, ... Schizophrenia research 116 (2), 191-195, 2010 | 45 | 2010 |
| In vivo 7Tesla imaging of the dentate granule cell layer in schizophrenia II Kirov, CJ Hardy, K Matsuda, J Messinger, CZ Cankurtaran, M Warren, ... Schizophrenia research 147 (2), 362-367, 2013 | 37 | 2013 |
| Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk TM Kranz, RR Goetz, J Walsh-Messinger, D Goetz, D Antonius, I Dolgalev, ... Schizophrenia research 168 (1), 421-428, 2015 | 31 | 2015 |
| Critical periods and the developmental origins of disease: an epigenetic perspective of schizophrenia M Perrin, K Kleinhaus, J Messinger, D Malaspina Annals of the New York Academy of Sciences 1204 (1), 8-13, 2010 | 31 | 2010 |
| Phenotypically distinct subtypes of psychosis accompany novel or rare variants in four different signaling genes TM Kranz, A Berns, J Shields, K Rothman, J Walsh-Messinger, RR Goetz, ... EBioMedicine 6, 206-214, 2016 | 27 | 2016 |
| Olfaction and cognition in schizophrenia: sex matters D Malaspina, A Keller, D Antonius, JW Messinger, DM Goetz, ... The Journal of neuropsychiatry and clinical neurosciences 24 (2), 165-175, 2012 | 26 | 2012 |
| The best COVID-19 predictor is recent smell loss: a cross-sectional study RC Gerkin, K Ohla, MG Veldhuizen, PV Joseph, CE Kelly, AJ Bakke, ... MedRxiv, 2020.07. 22.20157263, 2020 | 25 | 2020 |
